Clinical Trials
19
Active:0
Completed:9
Trial Phases
2 Phases
Phase 4:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (75.0%)Phase 4
1 (25.0%)STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
Not Applicable
Not yet recruiting
- Conditions
- ST Elevation Myocardial Infarction
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- IGLESIAS Juan Fernando
- Target Recruit Count
- 350
- Registration Number
- NCT05785897
- Locations
- 🇨🇭
Geneva University Hospitals, Geneva, Switzerland
Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)
Not Applicable
Not yet recruiting
- Conditions
- Left Main Coronary Artery Stenosis
- Interventions
- Device: LMCA PCI with Supraflex Cruz ultrathin-strut biodegradable polymer sirolimus-eluting stent (Sahajanand Medical Technologies Ltd., Surat, India).Drug: P2Y12 inhibitor-based SAPT after short DAPT
- First Posted Date
- 2022-12-14
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- IGLESIAS Juan Fernando
- Target Recruit Count
- 828
- Registration Number
- NCT05650411
- Locations
- 🇨🇭
Zurich University Hospital, Zürich, Switzerland
DIStal Versus COnventional Radial Access for COMPLEX Large-bore Percutaneous Coronary Intervention
Not Applicable
Recruiting
- Conditions
- Vascular Access Site Occlusion
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- IGLESIAS Juan Fernando
- Target Recruit Count
- 708
- Registration Number
- NCT05490238
- Locations
- 🇧🇪
CHU Saint-Pierre, Bruxelles, Belgium
🇧🇪CHU de Charleroi, Charleroi, Belgium
🇧🇪Hôpital de La Louvière - Site Jolimont, La Louvière, Belgium
News
No news found